Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Family Planning Counseling & the Rheumatologist

Arthritis Care & Research  |  February 6, 2018

Contraception: “Research evaluating contraceptive safety has focused primarily on SLE, RA and APS, but most [contraceptive] methods appear to be safe for women with other rheumatic diseases,” write the authors.

The reviewers emphasize the importance of contraceptive counseling in family planning, outlining the common side effects for patients with rheumatic disease, efficacy and reversibility of multiple methods. Although method selection should be guided by a patient’s individual preferences, women with chronic diseases who have an increased risk of pregnancy complications may consider contraceptive efficacy particularly important.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

According to research, progestin-only subdermal implants are the most effective contraceptives available (first-year failure rate 0.05%). But long-acting reversible contraceptives, such as intrauterine devices (IUDs), are also highly effective for preventing pregnancy.

“To benefit all rheumatic disease patients, providers may expand their competencies to provide patient-centered, respectful and comprehensive family planning counseling,” write the authors in their conclusion. “Education in family planning and patient-centered communication should be incorporated into specialty and subspecialty training. Through enhanced attention to family planning, we can empower individuals with rheumatic diseases to make important decisions to improve their health, and the well-being of their children and families.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Read the full article.

Birru Talabi M, Clowse MEB, Schwarz EB, et al. Family planning counseling for women with rheumatic diseases. Arthritis Care Res (Hoboken). 2018 Feb;70(2):169–174. doi: 10.1002/acr.23267.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsResearch Rheum Tagged with:Arthritis Care & Researchcounselingfamily planningpatient communicationphysician-patient communicationpregnancypregnant womenWomen

Related Articles

    Challenges in Reproductive Health in Rheumatic Disease

    July 11, 2022

    In light of new challenges to individuals’ reproductive rights and the known challenges of clinical management of rheumatic disease patients during pregnancy, we review the current state of reproductive rheumatology and the management of patients with rheumatic disease during pregnancy.

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    AndreyCherkasov / Shutterstock.com

    Rheumatic Disease Does Not Preclude Pregnancy

    November 9, 2017

    Preconception planning is essential to help women with autoimmune disease have optimal pregnancy outcomes. Unplanned pregnancy can also negatively impact disease course in some patients. Yet many rheumatologic patients of childbearing age do not receive adequate contraception or prepregnancy education and counseling. Rheumatologists must work collaboratively with other healthcare providers to make sure rheumatic patients…

    Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

    November 16, 2016

    The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences